Updates are available Correction dated 2025-12-03
Click to view Correction: https://doi.org/10.1186/s12943-025-02539-9
-
Authors
Ianniello, Zaira
Lu, Huimei
Quijano, Elias
Colón-Ríos, Daniel A.
Rackear, Madison
Bommireddy, Venu
Ludwig, Dale L.
Shen, Zhiyuan
Glazer, Peter M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01CA195612)
National Institutes of Health (R35CA197574)
Sponsored Research Award from Gennao Bio
- License Information
-
More Information
Article History
Received: 6 May 2025
Accepted: 30 August 2025
First Online: 13 October 2025
Change Date: 30 November 2025
Change Type: Update
Change Details: The original online version of this article was revised: Following publication of the original article [1], the authors reported the following errors listed in erratum 10.1186/s12943-025-02539-9.
Change Date: 3 December 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12943-025-02539-9
Declarations
:
: All animal studies were approved by the Yale University Institutional Animal Care and Use Committee, and all experiments were performed according to institutional animal care and use guidelines. Consent to Participate declaration: not applicable.
: Z.I., E.Q., and P.M.G. are inventors on pending patent applications assigned to Yale University related to the work. Z.I., E.Q., and P.M.G. are co-founders of Altera Therapeutics which is related to this work. E.Q. and P.M.G. were formerly consultants for and equity holders in Gennao Bio. P.M.G. also holds equity in Patrys, Ltd., is a founder of and consultant for Cybrexa Therapeutics, and is a consultant for pHLIP Inc. none of which have a connection to this manuscript.
